Taika Capital LP trimmed its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 63.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,595 shares of the financial services provider’s stock after selling 2,725 shares during the quarter. Taika Capital LP’s holdings in CME Group were worth $370,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Truvestments Capital LLC acquired a new stake in CME Group in the 3rd quarter valued at approximately $26,000. SJS Investment Consulting Inc. increased its position in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC increased its position in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 81 shares during the period. Financial Life Planners acquired a new stake in CME Group in the 4th quarter valued at approximately $32,000. Finally, Fortitude Family Office LLC increased its position in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Trading Up 0.2 %
Shares of CME opened at $254.57 on Monday. The business’s 50-day moving average price is $240.07 and its 200 day moving average price is $230.85. The stock has a market capitalization of $91.74 billion, a P/E ratio of 26.33, a P/E/G ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $258.78. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.
CME Group declared that its board has approved a stock repurchase plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its stock is undervalued.
CME Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.96%. CME Group’s payout ratio is currently 51.71%.
Insider Activity
In other news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. This represents a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,076 shares of company stock worth $4,271,496. 0.30% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of research firms recently commented on CME. Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Oppenheimer raised their price objective on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Keefe, Bruyette & Woods raised their price objective on shares of CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research note on Friday, February 14th. Barclays raised their price objective on shares of CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Finally, Royal Bank of Canada raised their price objective on shares of CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $235.50.
Check Out Our Latest Stock Report on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- How to Use the MarketBeat Excel Dividend Calculator
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Investing in the High PE Growth Stocks
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.